Small Hospitals
Market Cap
₹7,374 ₹7,374 Cr.
P/E
95.97
PEG = P/E ÷ 5yr forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

Key Ratios

Debt to Equity
Debt to Equity
0.02
Div Yield (%)
Div Yield (%)
-
Individual < 2 lac
Individual < 2 lac
3.75 %
Institutions
Institutions
17.83 %
Market cap
Market cap
7,374 Cr
No. of Shareholders
No. of Shareholders
44,091
OPM (%)
OPM (%)
21.85 %
PE
PE
95.97
Prom Holding
Prom Holding
63.85 %
ROCE (%)
ROCE (%)
14.14
ROE (%)
ROE (%)
6.88
Sales
Sales
1,034 Cr
  • Nephrocare Health
  • Narayana Hrudayalay.
  • Jupiter Life Line

Nothing to show here

This view can't be shown right now. We're continuously expanding and updating coverage across companies, so please check back again soon.

Nothing to show here

This view can't be shown right now. We're continuously expanding and updating coverage across companies, so please check back again soon.

Price Range

See where the stock is trading versus its 52-week high and low.

Low
446
52W Range
High
782
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

3 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • Revenue Per Treatment (Rs)
    • Total Number of Clinics

    Peer Comparison

    FAQs on Nephrocare Health Services Ltd. Business

    Nephrocare Health Services is engaged in offering comprehensive dialysis care through its network of clinics - from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy. Its widespread presence ensures patients have easy accessibility to dialysis services.

    Nephrocare Health major competitors are Narayana Hrudayalay., Jupiter Life Line, RainbowChildrenS Med, Dr. Agarwal's Health, Dr. Lal Pathlabs, Metropolis Health., Vijaya Diagnostic.
    Market Cap of Nephrocare Health is ₹7,370 Crs.
    While the median market cap of its peers are ₹14,721 Crs.

    Nephrocare Health seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Feb May Aug
    Investor Presentation Feb May Aug
    Conference Call Feb May Aug
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    []
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material